News
Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...
Insider Monkey on MSN15d
Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...
We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
In predicting a stock's future price performance, it's crucial to ... or not it's worthwhile paying attention to the market buzz about Pfizer. However, its Zacks Rank #2 does suggest that it ...
9d
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
The remarkable improvement was driven by the strong performance of Pfizer's core portfolio ... and then choose between a market order or a limit order to buy the stock. To sell shares of Pfizer ...
UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results